UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma

Journal of clinical oncology, 2008-10, Vol.26 (28), p.4579-4586

2008

Volltextzugriff (PDF)

Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature

British journal of haematology, 2012-10, Vol.159 (1), p.39-49

2012

Volltextzugriff (PDF)

Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

Current oncology (Toronto), 2021-03, Vol.28 (2), p.1256-1261

2021

Volltextzugriff (PDF)

Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12

JNCI : Journal of the National Cancer Institute, 2015-07, Vol.107 (7), p.1

2015

Volltextzugriff (PDF)

Resident duty hours: past, present, and future

BMC medical education, 2014-12, Vol.14 Suppl 1 (9036), p.S1-S1, Article S1

2014

Volltextzugriff (PDF)

Cost-Utility Analysis of Primary Prophylaxis Versus Secondary Prophylaxis With Granulocyte Colony-Stimulating Factor in Elderly Patients With Diffuse Aggressive Lymphoma Receiving Curative-Intent Chemotherapy

Journal of clinical oncology, 2012-04, Vol.30 (10), p.1064-1071

2012

Volltextzugriff (PDF)

Bortezomib Added to R-CVP Is Safe and Effective for Previously Untreated Advanced-Stage Follicular Lymphoma: A Phase II Study by the National Cancer Institute of Canada Clinical Trials Group

Journal of clinical oncology, 2011-09, Vol.29 (25), p.3396-3401

2011

Volltextzugriff (PDF)

Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario

Cancer treatment reviews, 2007-04, Vol.33 (2), p.161-176

2007

Volltextzugriff (PDF)

The case for a Canadian standard for 2SLGBTQIA+ medical education

Canadian Medical Association journal (CMAJ), 2021-04, Vol.193 (16), p.E562-E565

2021

Volltextzugriff (PDF)

Management of newly diagnosed high‐risk and intermediate‐risk follicular lymphoma with 90Y ibritumomab tiuxetan in a phase II study

Hematological oncology, 2018-08, Vol.36 (3), p.525-532

2018

Volltextzugriff (PDF)

Assessment of Gaps in Hematology Education in Canadian Internal Medicine Residency Programs

Blood, 2023-11, Vol.142 (Supplement 1), p.7192-7192

2023

Volltextzugriff (PDF)

Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with 90 Y ibritumomab tiuxetan in a phase II study

Hematological oncology, 2018-04, Vol.36 (3), p.525-532

2018

Volltextzugriff (PDF)

High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma

Leukemia & lymphoma, 2011-10, Vol.52 (10), p.1882-1890

2011

Volltextzugriff (PDF)

The impact of follicular (FL) and other indolent non-Hodgkin's lymphomas (NHL) on work productivity-a preliminary analysis

Psycho-oncology (Chichester, England), 2009-05, Vol.18 (5), p.554-559

2009

Volltextzugriff (PDF)

Arguments en faveur d’une norme canadienne pour l’intégration des enjeux 2SLGBTQIA+ dans les études de médecine

Canadian Medical Association journal (CMAJ), 2021-06, Vol.193 (24), p.E937-E941

2021

Volltextzugriff (PDF)

Eosinophils in the skin—a red herring masking lymphoma: a case series

SAGE open medical case reports, 2018, Vol.6, p.2050313X18773127

2018

Volltextzugriff (PDF)

A new era for resident duty hours in surgery calls for greater emphasis on resident wellness

Canadian Journal of Surgery, 2013-10, Vol.56 (5), p.295-296

2013

Volltextzugriff (PDF)

A Systematic Review of the Effects of Resident Duty Hour Restrictions in Surgery: Impact on Resident Wellness, Training, and Patient Outcomes

Annals of surgery, 2014-06, Vol.259 (6), p.1041-1053

2014

Volltextzugriff (PDF)

Chronic Lymphocytic Leukemia-reactive T Cells during Disease Progression and after Autologous Tumor Cell Vaccines

Clinical cancer research, 2003-05, Vol.9 (5), p.1656-1665

2003

Volltextzugriff (PDF)

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

Blood, 2005-02, Vol.105 (4), p.1417-1423

2005

Volltextzugriff (PDF)

Core Competencies or a Competent Core? A Scoping Review and Realist Synthesis of Invasive Bedside Procedural Skills Training in Internal Medicine

Academic medicine, 2017-11, Vol.92 (11), p.1632-1643

2017

Volltextzugriff (PDF)

The Impact of Clonal Hematopoiesis on Clinical Outcomes and Clonal Dynamics in Older Lymphoma Patients Receiving Chemotherapy

Blood, 2023-11, Vol.142 (Supplement 1), p.442-442

2023

Volltextzugriff (PDF)

Targeting the follicular lymphoma microenvironment - Ready for prime-time?

Leukemia & lymphoma, 2008-01, Vol.49 (5), p.837-838

2008

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(107)

Publikationsform

Sprache

Englisch
(131)

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(66)
Humans
(65)
Female
(35)
Middle Aged
(34)
Male
(33)
Adult
(32)
Oncology
(26)
Hematology
(21)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Biological And Medical Sciences
(19)
Medical Sciences
(18)
Aged
(17)
Rituximab
(14)
Treatment Outcome
(13)
Antineoplastic Combined Chemotherapy Protocols - Administration & Dosage
(11)
Lymphoma, Non-Hodgkin - Drug Therapy
(11)
Transplantation, Autologous
(11)
Adolescent
(10)
Lymphoma
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12

Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma

Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature

Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12

Resident duty hours: past, present, and future

Cost-Utility Analysis of Primary Prophylaxis Versus Secondary Prophylaxis With Granulocyte Colony-Stimulating Factor in Elderly Patients With Diffuse Aggressive Lymphoma Receiving Curative-Intent Chemotherapy

Bortezomib Added to R-CVP Is Safe and Effective for Previously Untreated Advanced-Stage Follicular Lymphoma: A Phase II Study by the National Cancer Institute of Canada Clinical Trials Group

Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario

The case for a Canadian standard for 2SLGBTQIA+ medical education

Management of newly diagnosed high‐risk and intermediate‐risk follicular lymphoma with 90Y ibritumomab tiuxetan in a phase II study

Assessment of Gaps in Hematology Education in Canadian Internal Medicine Residency Programs

Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with 90 Y ibritumomab tiuxetan in a phase II study

High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma

The impact of follicular (FL) and other indolent non-Hodgkin's lymphomas (NHL) on work productivity-a preliminary analysis

Arguments en faveur d’une norme canadienne pour l’intégration des enjeux 2SLGBTQIA+ dans les études de médecine

Eosinophils in the skin—a red herring masking lymphoma: a case series

A new era for resident duty hours in surgery calls for greater emphasis on resident wellness

A Systematic Review of the Effects of Resident Duty Hour Restrictions in Surgery: Impact on Resident Wellness, Training, and Patient Outcomes

Chronic Lymphocytic Leukemia-reactive T Cells during Disease Progression and after Autologous Tumor Cell Vaccines

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

Core Competencies or a Competent Core? A Scoping Review and Realist Synthesis of Invasive Bedside Procedural Skills Training in Internal Medicine

The Impact of Clonal Hematopoiesis on Clinical Outcomes and Clonal Dynamics in Older Lymphoma Patients Receiving Chemotherapy

Targeting the follicular lymphoma microenvironment - Ready for prime-time?

Suchergebnisse filtern